DFDA

Lisinopril

Treatment for Chronic Kidney Disease Due To Diabetes Mellitus Type 2

Typical Dosage: Lisinopril 10-40mg daily

Effectiveness
90%
Safety Score
70%
Clinical Trials
1,000
Participants
2M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Lisinopril 10-40mg daily
Time to Effect
1-2 months for albuminuria reduction, 6-12 months for sustained eGFR benefit
Treatment Duration
lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
15(Treat 15 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
98%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$180
Monitoring:$1,200
Side Effect Mgmt:$75
Total Annual:$1,455
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$20,000/QALY
QALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$1,711.76
Lisinopril Outcomes

for Chronic Kidney Disease Due To Diabetes Mellitus Type 2

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+85%
Common Side Effects
Cough
+10%
Hyperkalemia
+5%
Hypotension
+3%

Sources:

oup.com
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov